Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.
about
Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infectionSystematic review: the use of proton pump inhibitors and increased susceptibility to enteric infectionThe changing epidemiology of Clostridium difficile infectionsComplete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort studyMulticenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.A time-series analysis of clostridium difficile and its seasonal association with influenza.A review of the economics of treating Clostridium difficile infection.Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisitionHospital Transfer Network Structure as a Risk Factor for Clostridium difficile InfectionHospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.Clostridium difficile infection: a re-emerging threat.Development and validation of a Clostridium difficile infection risk prediction model.Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.Clostridium difficile: The evolving storyMeasurement and Impact of Staphylococcus aureus Colonization Pressure in Households.Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.Antibiotic-associated diarrhea: epidemiology, trends and treatment.Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI.Clostridium difficile infection in the intensive care unit.Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.Diverse sources of C. difficile infection identified on whole-genome sequencing.Is Clostridium difficile infection a particular problem after reversal of ileostomy?Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.Clostridium difficile surveillance: harnessing new technologies to control transmission.Surgical Management of Severe Colitis in the Intensive Care Unit.Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed.Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis.The drivers of acute and long-term care C. difficile infection rates: a retrospective multilevel cohort study of 251 facilities.Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities.Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients.Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.A sustained endemic outbreak of vancomycin-resistant Enterococcus faecium: A 30-month surveillance study.Transmission of Clostridium difficile spores in isolation room environments and through hospital beds.Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
P2860
Q24632307-2C2BBAA7-7544-4124-8B7D-4C944ED490DDQ26849521-5CD45395-A323-4E07-BE1A-240209366F01Q28750385-B1BE69BC-1CF4-4ABF-B5AE-21AE76047D8FQ30228253-EEB9D89B-12C9-40FC-8298-85E683B682C4Q34089890-0D049FC0-E324-49E4-9CBF-E370F781D8E3Q34141945-6D695C89-A343-4C4F-AD15-3F8ED4DE4AF3Q34331595-72AB4FD2-0859-4E23-8EAA-F7C2DF47084AQ34509883-D8424D1C-AAD4-4CB3-A051-58A52E294519Q35164905-D68DC531-7C7C-4ECD-B867-33D330B9AE0AQ35603344-07861610-69D9-4086-B42D-A349FBBE6438Q36053985-17DE1DA0-E226-4E22-AAC9-38074D4B62F0Q36059951-4A621999-E560-4C02-8972-110D28E24688Q36531406-E1C153AE-CF89-4EAF-81DB-4E4D61849AB5Q36687670-B70E4B4A-5EAF-42AC-B9D1-8390EAED0255Q36717591-C7015831-2EE1-42F7-B592-B32F02B07ACBQ36726659-A7F30A1D-F9D7-4756-B3E0-7311BFD06A33Q36827540-8C50DA39-9FB9-4ECA-B17E-AEBC9FE7C810Q36831098-A685572B-E331-4066-A248-0DFEA08F54C3Q36870734-9B123521-8BD4-4901-B12C-353935BEA45CQ36871148-17EBD3D2-8FD5-4BAE-B2AB-03CAE45805DFQ36880168-DB301C3C-0D50-4C72-8158-CB3E9F4D7CADQ37122896-92D93288-30F8-4E4C-A98F-5950A9D02648Q37277087-923BB7CF-5500-4A22-9C3A-3B16DE778228Q37292571-8850E315-3188-43BE-B801-F31265A363A8Q37305032-C8F0A218-A3C8-4EB0-82A1-26967C2185F7Q37317503-CD2219C5-5850-45C2-916B-8F11610C8AC3Q37405479-954FDFA4-2CD0-4E62-86DB-7AD0934CE9BDQ37635283-581DCB5F-E172-466D-917B-CC9239B860BAQ38004673-7D508293-4730-4BE4-BBE3-CBD2D1453903Q38154925-E4C76B96-DA88-4756-97BA-F05DC5242818Q38214577-83AB8091-FB97-45BE-8C08-9C3C81BCFB58Q39305335-DAF200F8-8416-4504-A217-4435B7E0C405Q39307398-F43A0B6A-AD5B-49A7-AE8F-6DFBBE97F75AQ40179998-3C70D237-B8D5-4356-BB7A-FC12360DE58FQ40190305-6E861ADB-B3A2-42E5-AE77-90366CAAD551Q40681467-CE24883B-A159-42F7-B8A7-BD8EB1F1C7A4Q41076074-A1F64635-4F60-422B-B383-93989308331AQ42215083-A71C6BD2-CC16-424C-93FB-A239F8780F18Q42230696-6B5855BE-6EDC-4C43-846A-B49EEF3415E3Q42695192-3DEBAB46-3EE5-4430-94F4-ABF60CD1E225
P2860
Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evaluation of Clostridium diff ...... difficile-associated disease.
@en
type
label
Evaluation of Clostridium diff ...... difficile-associated disease.
@en
prefLabel
Evaluation of Clostridium diff ...... difficile-associated disease.
@en
P2093
P1476
Evaluation of Clostridium diff ...... difficile-associated disease.
@en
P2093
Jennie L Mayfield
Kathleen M McMullen
Kimberly A Reske
L Clifford McDonald
Margaret A Olsen
Victoria J Fraser
P304
P356
10.1001/ARCHINTE.167.10.1092
P407
P577
2007-05-01T00:00:00Z